GT BIOPHARMA INC's ticker is GTBP and the CUSIP is 36254L209. A total of 22 filers reported holding GT BIOPHARMA INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | -100.0% | 2,436 | -36.2% | 0.00% | – |
| Q2 2023 | $2,000 | +100.0% | 3,819 | +52.3% | 0.00% | – |
| Q1 2023 | $1,000 | -99.6% | 2,508 | -99.1% | 0.00% | – |
| Q4 2022 | $250,000 | +8233.3% | 281,958 | +13534.3% | 0.00% | – |
| Q3 2022 | $3,000 | -50.0% | 2,068 | +5.6% | 0.00% | – |
| Q2 2022 | $6,000 | -33.3% | 1,958 | -35.8% | 0.00% | – |
| Q1 2022 | $9,000 | -55.0% | 3,049 | -52.2% | 0.00% | – |
| Q4 2021 | $20,000 | -28.6% | 6,377 | +54.3% | 0.00% | – |
| Q3 2021 | $28,000 | -49.1% | 4,134 | +15.2% | 0.00% | – |
| Q2 2021 | $55,000 | -67.1% | 3,590 | -85.4% | 0.00% | – |
| Q1 2021 | $167,000 | – | 24,542 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 2,200,020 | $1,210,011 | 0.02% |
| Baskin Financial Services Inc. | 151,354 | $83 | 0.01% |
| Moss Adams Wealth Advisors LLC | 10,000 | $5,500 | 0.00% |
| Atria Wealth Solutions, Inc. | 68,720 | $37,796 | 0.00% |
| Compagnie Lombard Odier SCmA | 50,000 | $27,500 | 0.00% |
| Tower Research Capital LLC (TRC) | 28,415 | $16 | 0.00% |
| UBS Group AG | 7,793 | $4,286 | 0.00% |
| IFP Advisors, Inc | 50 | $259 | 0.00% |
| OSAIC HOLDINGS, INC. | 1,017 | $559 | 0.00% |
| FMR LLC | 101,764 | $55,970 | 0.00% |